Latest News

Filters

Filter by tags: Europe CANDU reactor Clear all tag filters

31 news articles found

The deployment of four AP1000 units in Ontario could have an impact of more than CAD28.7 billion (USD21.2 billion) on Canada's GDP during the manufacturing, engineering and construction phase alone, an independent study has found.

Source: World Nuclear News
Date: Friday, 01 March 2024
Original article: world-nuclear-news.org/Articles/Canadian-AP1000-deployment-could-bring-billions-in

Romanian nuclear utility Societatea Nationala Nuclearelectrica (SNN) and the European Investment Bank (EIB) have signed a loan agreement worth €145m ($159m) to support completion of Europe’s first Tritium Removal Facility (CTRF) at the Cernavoda NPP. The CTRF will remove the tritium from reactor’s coolant and moderator (heavy water), leading to increased protection of the environment, public and employees’ occupational health and safety.

Source: NEI Magazine
Date: Thursday, 11 January 2024
Original article: neimagazine.com/news/newseib-to-fund-tritium-removal-facility-in-romania-11426539

Romania's Nuclearelectrica and France's Framatome have signed a cooperation agreement on exploring the production of the medical isotope lutetium-177 at the Cernavoda nuclear power plant.

Source: World Nuclear News
Date: Friday, 01 December 2023
Original article: world-nuclear-news.org/Articles/Nuclearelectrica-and-Framatome-in-Lutetium-177-agr

Canada and Romania have signed a CAD3bn ($2.2bn) export development deal to support construction of two new units at the Cernavoda NPP. Canadian Energy Minister Jonathan Wilkinson said the financing offer for Romania’s national nuclear operator, Nuclearelectrica, to buy supplies or services from Canadian companies.

Source: NEI Magazine
Date: Friday, 22 September 2023
Original article: neimagazine.com/news/newscanada-agrees-funding-for-cernavoda-expansion-11163290

European country aiming to phase out coal by 2032

Source: Nucnet
Date: Friday, 22 September 2023
Original article: nucnet.org/news/canada-announces-cad-3-billion-financing-for-two-new-candu-reactors-at-cernavoda-9-4-2023

The Canadian Minister of Energy and Natural Resources Jonathan Wilkinson has announced CAD3 billion (USD2.2 billion) of export financing to Nuclearelectrica to support the building of two CANDU-6 reactors at the Cernavoda nuclear power plant in Romania.

Source: World Nuclear News
Date: Thursday, 21 September 2023
Original article: world-nuclear-news.org/Articles/Canada-offers-CAD3-billion-finance-for-new-nuclear

Romanian nuclear utility Societatea Nationala Nuclearelectrica (SNN), and Korea Hydro & Nuclear Power (KHNP) have signed an Engineering, Procurement & Construction (EPC) contract for construction of the Cernavoda Tritium Removal Facility (CTRF).

Source: NEI Magazine
Date: Friday, 30 June 2023
Original article: neimagazine.com/news/newsnuclearelectrica-and-khnp-to-construct-tritium-removal-facility-at-cernavoda-npp-10974947

Korea Hydro & Nuclear Power (KHNP) has signed a contract worth KRW260 billion (USD200 million) to construct a tritium removal facility at Romania's Cernavoda nuclear power plant site. The facility will use technology developed by Romania.

Source: World Nuclear News
Date: Wednesday, 28 June 2023
Original article: world-nuclear-news.org/Articles/Contract-for-Cernavoda-tritium-removal-facility

Romanian nuclear utility SN Nuclearelectrica (SNN) and the Polytechnic University of Bucharest (UPB) have launched a NuScale Power Energy Exploration Centre (E2 Centre) at the University’s Faculty of Energy Engineering. It includes a control room simulator for NuScale’s VOYGR small modular reactor (SMR) power plant. It is the first E2 Centre to be established outside the USA. The first E2 Centre was opened at Oregon State University in 2020.

Source: NEI Magazine
Date: Thursday, 18 May 2023
Original article: neimagazine.com/news/newsus-supports-opening-of-nuscales-energy-exploration-centre-in-romania-10858705

Advances in emerging field of ‘theranostics’ are a game-changer Millions of patients around the globe rely on the regular and timely production of diagnostic and therapeutic isotopes produced in research reactors and accelerator facilities. Image courtesy IAEA. Advances in medical isotope diagnostics and therapy are holding promise for cancer patients, despite challenges facing the nuclear medical field in recent years related to radionuclide production and supply, rising costs, and stricter regulation.

Medical isotopes are radioactive substances used in various diagnostic and therapeutic procedures to treat various types of cancers and other conditions. They are essential for modern medicine, allowing physicians to visualise and target specific organs, tissues and cells in a patient’s body.

Over more than a decade, personalised medicine using nuclear techniques has been gaining pace, allowing doctors to tailor therapies and treatments to the specific needs and physiology of a patient, and to avoid harm to healthy organs or tissues.

According to Sven Van den Berghe, chief executive of Belgium-based isotope producer PanTera, one technique that has seen significant advances is known as theranostics – the term used to describe the combination of using one radioactive drug to diagnose and a second to deliver therapy to treat the main tumour and any metastatic tumours.

Source: Nucnet
Date: Friday, 14 April 2023
Original article: nucnet.org/news/sector-aims-to-tackle-isotope-supply-problems-as-excitement-grows-over-targeted-therapies-4-4-2023

Load more news